• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质金属蛋白酶在血管重塑中的作用。

Role of matrix metalloproteinases in vascular remodeling.

作者信息

Kuzuya Masafumi, Iguchi Akihisa

机构信息

Department of Geriatrics, Nagoya University Graduate School of Medicine, Nagoya, Japan.

出版信息

J Atheroscler Thromb. 2003;10(5):275-82. doi: 10.5551/jat.10.275.

DOI:10.5551/jat.10.275
PMID:14718744
Abstract

Vascular remodeling, defined as lasting structural changes in the vessel wall in response to hemodynamic stimuli, plays a role in many (patho)physiological processes requiring cell migration and degradation of extracellular matrix(ECM). Matrix metalloproteinase(MMP) system can degrade most ECM components. Several lines of evidence support a role for MMP system components in the development and progression of atherosclerosis and restenosis after angioplasty. This review article focuses on the role of MMPs in vascular remodeling relevant to atherosclerosis and restenosis after angioplasty.

摘要

血管重塑被定义为血管壁对血流动力学刺激做出的持久结构变化,在许多需要细胞迁移和细胞外基质(ECM)降解的(病理)生理过程中发挥作用。基质金属蛋白酶(MMP)系统能够降解大多数ECM成分。多条证据支持MMP系统成分在动脉粥样硬化发展以及血管成形术后再狭窄过程中发挥作用。这篇综述文章聚焦于MMPs在与动脉粥样硬化及血管成形术后再狭窄相关的血管重塑中的作用。

相似文献

1
Role of matrix metalloproteinases in vascular remodeling.基质金属蛋白酶在血管重塑中的作用。
J Atheroscler Thromb. 2003;10(5):275-82. doi: 10.5551/jat.10.275.
2
Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.基质金属蛋白酶:血管生成和重塑中调节细胞行为的炎症调控因子。
Mediators Inflamm. 2013;2013:928315. doi: 10.1155/2013/928315. Epub 2013 Jun 12.
3
Metalloproteinases in development and progression of vascular disease.金属蛋白酶在血管疾病发生发展中的作用
Pathophysiol Haemost Thromb. 2003;33(5-6):275-81. doi: 10.1159/000083814.
4
Plasmin and matrix metalloproteinases in vascular remodeling.血管重塑中的纤溶酶与基质金属蛋白酶
Thromb Haemost. 2001 Jul;86(1):324-33.
5
Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.动脉粥样硬化中的炎症机制:基质金属蛋白酶的影响。
Curr Top Med Chem. 2012;12(10):1132-48. doi: 10.2174/1568026611208011132.
6
Matrix Metalloproteinase 2 as a Potential Mediator of Vascular Smooth Muscle Cell Migration and Chronic Vascular Remodeling in Hypertension.基质金属蛋白酶2作为高血压中血管平滑肌细胞迁移和慢性血管重塑的潜在介质
J Vasc Res. 2015;52(4):221-31. doi: 10.1159/000441621. Epub 2016 Jan 6.
7
Native and minimally oxidized low density lipoprotein depress smooth muscle matrix metalloproteinase levels.天然及轻度氧化的低密度脂蛋白降低平滑肌基质金属蛋白酶水平。
Mol Cell Biochem. 2003 Jul;249(1-2):141-9.
8
[Extracellular matrix and atherosclerosis].
J UOEH. 2010 Jun 1;32(2):195-203. doi: 10.7888/juoeh.32.195.
9
Matrix metalloproteinases in vascular physiology and disease.基质金属蛋白酶在血管生理与疾病中的作用
Vascular. 2012 Aug;20(4):210-6. doi: 10.1258/vasc.2011.201202. Epub 2012 Aug 15.
10
Biochemical and Biological Attributes of Matrix Metalloproteinases.基质金属蛋白酶的生化及生物学特性
Prog Mol Biol Transl Sci. 2017;147:1-73. doi: 10.1016/bs.pmbts.2017.02.005. Epub 2017 Mar 22.

引用本文的文献

1
Metalloproteinases (MMPs) in hypertensive disorders: role, function, pharmacology, and potential strategies to mitigate pathophysiological changes.高血压疾病中的金属蛋白酶(MMPs):作用、功能、药理学及减轻病理生理变化的潜在策略
Front Pharmacol. 2025 May 26;16:1559288. doi: 10.3389/fphar.2025.1559288. eCollection 2025.
2
The role of matrix metalloproteinase expression levels in the pathogenesis of tympanosclerosis.基质金属蛋白酶表达水平在鼓室硬化症发病机制中的作用。
Eur Arch Otorhinolaryngol. 2025 Jun 4. doi: 10.1007/s00405-025-09509-3.
3
Blockade of ZFX Alleviates Hypoxia-Induced Pulmonary Vascular Remodeling by Regulating the YAP Signaling.
阻断 ZFX 通过调控 YAP 信号减轻低氧诱导的肺血管重构。
Cardiovasc Toxicol. 2024 Feb;24(2):158-170. doi: 10.1007/s12012-023-09822-5. Epub 2024 Feb 3.
4
Avenanthramide C Suppresses Matrix Metalloproteinase-9 Expression and Migration Through the MAPK/NF- κB Signaling Pathway in TNF-α-Activated HASMC Cells.芹当归酰胺C通过MAPK/NF-κB信号通路抑制TNF-α激活的人主动脉平滑肌细胞中基质金属蛋白酶-9的表达和迁移。
Front Pharmacol. 2021 Mar 25;12:621854. doi: 10.3389/fphar.2021.621854. eCollection 2021.
5
Synergistic enhancement of matrix metalloproteinase-9 expression and pro-inflammatory cytokines by influenza virus infection and oxidized-LDL treatment in human endothelial cells.流感病毒感染和氧化低密度脂蛋白处理对人内皮细胞基质金属蛋白酶-9表达及促炎细胞因子的协同增强作用
Exp Ther Med. 2017 Nov;14(5):4579-4585. doi: 10.3892/etm.2017.5099. Epub 2017 Sep 1.
6
Chebulinic acid inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression.齐墩果酸通过抑制 PDGF-Rβ 磷酸化和基质金属蛋白酶-2 的表达抑制平滑肌细胞迁移。
Sci Rep. 2017 Sep 18;7(1):11797. doi: 10.1038/s41598-017-12221-w.
7
Magnobovatol inhibits smooth muscle cell migration by suppressing PDGF-Rβ phosphorylation and inhibiting matrix metalloproteinase-2 expression.厚朴酚通过抑制血小板衍生生长因子受体β(PDGF-Rβ)磷酸化和基质金属蛋白酶-2(MMP-2)表达来抑制平滑肌细胞迁移。
Int J Mol Med. 2016 May;37(5):1239-46. doi: 10.3892/ijmm.2016.2548. Epub 2016 Apr 4.
8
Comparison of Aortic Collagen Fiber Angle Distribution in Mouse Models of Atherosclerosis Using Second-Harmonic Generation (SHG) Microscopy.使用二次谐波产生(SHG)显微镜比较动脉粥样硬化小鼠模型中主动脉胶原纤维角度分布
Microsc Microanal. 2016 Feb;22(1):55-62. doi: 10.1017/S1431927615015585. Epub 2016 Jan 7.
9
C/EBPβ and Nuclear Factor of Activated T Cells Differentially Regulate Adamts-1 Induction by Stimuli Associated with Vascular Remodeling.C/EBPβ和活化T细胞核因子对与血管重塑相关刺激诱导的Adamts-1的调控存在差异。
Mol Cell Biol. 2015 Oct;35(19):3409-22. doi: 10.1128/MCB.00494-15. Epub 2015 Jul 27.
10
Matrix metalloproteinases and risk stratification in patients undergoing surgical revascularisation for critical limb ischaemia.基质金属蛋白酶与严重肢体缺血患者接受外科血管重建术时的风险分层
Int Wound J. 2016 Aug;13(4):493-9. doi: 10.1111/iwj.12464. Epub 2015 May 27.